PDL BIOPHARMA, INC. (33) | Indenture Agreements (2)
- Indenture, dated September 17, 2019, between PDL, BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee (Filed With SEC on September 17, 2019)
- Supplemental Indenture, dated September 17, 2019 by and between PDL BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee (Filed With SEC on September 17, 2019)
